Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
Influenza and Other Respiratory Viruses · 2025-11 · 19 (11)
DOI: 10.1111/irv.70190 ↗Abstract
ABSTRACT We estimated the burden of influenza, SARS‐CoV‐2 and RSV from patients hospitalized with acute respiratory infection systematically tested between weeks 40/2024 and 20/2025 in Spain. The hospitalization rate per 100,000 was highest for influenza [67.5 (95% Confidence Interval: 52.5–87.3)] followed by RSV [46.6 (35.4–62.2)] and SARS‐CoV‐2 [15.8 (10.2–24.6)]. Hospitalization rates peaked in ≥ 60‐year‐olds and < 5‐year‐olds, ICU admissions in < 1‐year‐olds and deaths in ≥ 80‐year‐olds. Hospitalization for SARS‐CoV‐2 at 80–85 years was comparable to influenza at 60–65 years, potentially signaling the appropriateness of increasing the COVID‐19 vaccination age cut‐off. RSV prevention appeared a priority in < 5‐year‐olds but substantial preventive potential was identified in the elderly.
EUVIMED